SCHEMBL3949679

SCHEMBL3949679

O=[C]CCCC1CCN(CCCC2CCOC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 13/20 0.38
CHRM1 P11229 13/20 0.38
CHRM3 P20309 13/20 0.38
CHRM2 P08172 12/20 0.38
CHRM4 P08173 12/20 0.38
DRD2 P14416 8/20 0.36
DRD4 P21917 8/20 0.36
DRD3 P35462 7/20 0.36
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
GNAO1 P09471 1/20 0.32
S1PR5 Q9H228 1/20 0.32
GAA P10253 1/20 0.32
HTR1A P08908 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044981 0.94 CHRM2 (0.36) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL3957672 0.93 CYP1A2 (0.38) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL3950123 0.91 ALDH1A1 (0.32) ALDH1A1S1PR5
SCHEMBL3956154 0.87 CYP1A2 (0.35) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL3950039 0.85 ALDH1A1 (0.32) ALDH1A1
SCHEMBL3949506 0.84 ALDH1A1 (0.35) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL3950074 0.82 ALDH1A1 (0.32) ALDH1A1S1PR5GAA
SCHEMBL3950772 0.82 ALDH1A1 (0.36) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL3949683 0.80 CHRM1 (0.33) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL3956741 0.79 ALDH1A1 (0.39) DRD2DRD3ALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009024825-A1 2-PYRAZINYLBENZIMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed